Piper Sandler reiterated coverage on Synlogic with a new price target
$SYBX
Biotechnology: Pharmaceutical Preparations
Health Care
Piper Sandler reiterated coverage of Synlogic with a rating of Overweight and set a new price target of $9.00 from $7.00 previously